Other processes covered by Tasy EMR include comprehensive, clinically integrated bed management and the scheduling of rooms and staff for appointments and medical procedures. By managing both clinical and administrative workflows, Tasy EMR connects the dots between different aspects of patient care. Designed to be highly flexible through traceable user roles and profiles, it keeps pace with a hospital's workflows, standards and key performance indicators.
Advanced clinical decision support tools

Ad Statistics
Times Displayed: 46131
Times Visited: 1302 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
As part of the customization of Tasy EMR functionalities, St. Andrew's Toowoomba Hospital will get access to advanced clinical decision support tools and full closed loop medication management. Medication errors and unsafe medication practices are a concern to hospital systems across the world. It is estimated that in Australia alone, the annual medication error-related costs are at least $1.2 billion [2].
Expanding full suite decision support solution across the globe
This new partnership agreement between Philips and St. Andrew's Toowoomba Hospital is another important step in the Tasy EMR growth success story beyond Latin America, the Middle East and Europe. The use of Tasy EMR has already helped multiple Brazilian hospitals receive EMR Adoption Model Stage 6 and Model Stage 7 (the highest level possible) certification from HIMSS Analytics; meaning they are near paperless and are driving integration, security and analytics to optimise patient care.
[1] Philips Tasy EMR is not available for sale in the USA.
[2] Australian Commission on Safety and Quality in Healthcare; October 9, 2017 https://www.safetyandquality.gov.au/media_releases/australia-joins-international-push-to-halve-medication-errors/
For further information, please contact:
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.
Back to HCB News